[
    [
        {
            "time": "",
            "original_text": "公告精选：长江电力举牌川投能源、国投电力；用友网络等去年业绩大增",
            "features": {
                "keywords": [
                    "长江电力",
                    "举牌",
                    "川投能源",
                    "国投电力",
                    "用友网络",
                    "业绩大增"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "电力",
                    "能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "公告精选：长江电力举牌川投能源、国投电力；用友网络等去年业绩大增",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "凯莱英：2018年净利同比增25% 拟10派4元",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2018年",
                    "净利",
                    "同比增25%",
                    "拟10派4元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英：2018年净利同比增25% 拟10派4元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "凯莱英：2018年净利润4.28亿元 拟10派4元",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2018年",
                    "净利润",
                    "4.28亿元",
                    "拟10派4元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英：2018年净利润4.28亿元 拟10派4元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "凯莱英(002821.SZ)2018年净利润升25.49%至4.28亿元 拟10派4元",
            "features": {
                "keywords": [
                    "凯莱英",
                    "002821.SZ",
                    "2018年",
                    "净利润",
                    "升25.49%",
                    "4.28亿元",
                    "拟10派4元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英(002821.SZ)2018年净利润升25.49%至4.28亿元 拟10派4元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "凯莱英：2018年净利润同比增25.49%，拟10派4元",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2018年",
                    "净利润",
                    "同比增25.49%",
                    "拟10派4元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英：2018年净利润同比增25.49%，拟10派4元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]